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Abstract
Glaucoma is a widespread ocular disease and major cause of blindness characterized by progressive, irreversible damage of
the optic nerve. Although the degenerative loss of retinal ganglion cells (RGC) and visual deficits associated with glaucoma
have been extensively studied, we hypothesize that glaucoma will also lead to alteration of the circadian timing system.
Circadian and non-visual responses to light are mediated by a specialized subset of melanopsin expressing RGCs that
provide photic input to mammalian endogenous clock in the suprachiasmatic nucleus (SCN). In order to explore the
molecular, anatomical and functional consequences of glaucoma we used a rodent model of chronic ocular hypertension, a
primary causal factor of the pathology. Quantitative analysis of retinal projections using sensitive anterograde tracing
demonstrates a significant reduction (,50–70%) of RGC axon terminals in all visual and non-visual structures and notably in
the SCN. The capacity of glaucomatous rats to entrain to light was challenged by exposure to successive shifts of the light
dark (LD) cycle associated with step-wise decreases in light intensity. Although glaucomatous rats are able to entrain their
locomotor activity to the LD cycle at all light levels, they require more time to re-adjust to a shifted LD cycle and show
significantly greater variability in activity onsets in comparison with normal rats. Quantitative PCR reveals the novel finding
that melanopsin as well as rod and cone opsin mRNAs are significantly reduced in glaucomatous retinas. Our findings
demonstrate that glaucoma impacts on all these aspects of the circadian timing system. In light of these results, the classical
view of glaucoma as pathology unique to the visual system should be extended to include anatomical and functional
alterations of the circadian timing system.
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Introduction
The hallmark of glaucoma is the degenerative loss of retinal
ganglion cells (RGCs) and their optic nerve fibers. In the absence of
adequate treatment glaucoma inevitably leads to blindness and is
expected to affect more than 60 million people worldwide by 2010
[1]. Although glaucoma results from multiple factors and likely
comprises a family of diseases, raised chronic intraocular pressure
(IOP) represents a significant risk factor [2–7]. The primary
symptom of glaucoma is an initial reduction of the peripheral visual
field withthe degreeoflossevolving proportionaltoRGCloss [8–9].
Previous studies in both humans and inmonkey models of glaucoma
initially reported that larger soma sized RGCs were primarily
susceptible to injury or damage [10–13]. However, a recent study
found that all classes of RGCs follow a similar time course of
degeneration beginning from the early stages of the disease [14].
In the mammalian retina, the light sensitive RGCs that express
the photopigment melanopsin [15–18] comprise a specific subset
(,1%) of large sized ganglion cells that regulate the photic
synchronisation of circadian rhythms and more generally, a
spectrum of ‘‘non-visual responses’’ to light including the acute
suppression of melatonin, pupillary constriction, alertness and
masking [19–23]. These RGCs mainly project to ‘‘non image-
forming’’ structures including the suprachiasmatic nucleus (SCN),
intergeniculate leaflet (IGL), olivary pretectal nucleus (OPN),
lateral hypothalamus and preoptic regions [16,24–25]. Minor
input has also been demonstrated to the dorsal lateral geniculate
nucleus (dLGN [18]) and superior colliculus (SC [24]). Functional
invalidation of melanopsin photopigment in Opn4
2/2 mice leads to
attenuated circadian [16,20,21,26], pupillary [27] and electro-
physiological responses to light [28] while the absence of
functional rods, cones and melanopsin results in a total inability
to respond to light [21,26]. Ocular pathologies and blindness in
humans are also associated with circadian and sleep disorders that
depend on the degree of conserved light perception [29–31].
Presently, however, there is no clear support for the commonly
held hypothesis of the impact of glaucoma on circadian and/or
sleep disturbances and the degenerative loss of melanopsin RGCs
in this pathology is controversial. One study [14] provided
evidence that melanopsin RGC degeneration is proportional to
that of the entire ganglion cell population, while a second report
[32] claimed selective sparing of melanopsin neurons.
To explore the hypothesis that glaucoma leads to alterations in
both the visual and non-visual systems we used a rat model of
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strategy that combines three novel functional and behavioral
approaches. We address several questions that have not previously
been probed in studies of glaucoma. Based on findings that RGC
somas degenerate in glaucoma, to what extent are their axonal
fiber projections to different brain target structures affected? If the
photic input pathway to the SCN is altered in glaucoma, does this
impact on the capacity for light entrainment by the circadian
timing system? How do degenerative changes of glaucoma alter
photopigment expression in the inner and outer retina?
Materials and Methods
Animals
Male Wistar rats (n=30) were housed individually in propylene
cages, under a 12:12 LD cycle, with food and water ad libitum. Eye
surgery for inducing experimental glaucoma was performed at 3–6
months of age. Anatomical and behavioral investigations were
undertaken on animals between the ages of 6–12 months.
Experiments were conducted in accordance with current national
(De ´cret No. 87-848), international (EU guidelines) and institution-
al regulations for animal husbandry and surgical procedures.
Laser Technique for raised intra-ocular pressure
Argon laser treatment (blue-green argon laser; Coherent, Palo
Alto, CA) of the episcleral veins (responsible for aqueous outflow
tissue) was used to induce chronic elevation of IOP according to
previous methods [33]. Rats were anesthetized with a mixture of
ketamine (50 mg/kg), acepromazine (1 mg/kg), and xylazine
(25 mg/kg). Laser treatment was performed unilaterally (n=12,
for the anatomical study) or bilaterally (n=5, for the behavioral
study) in three stages on the episcleral veins within 0.5 to 0.8 mm
from the limbus and on the veins in the limbus. The first two
surgeries occurred one week apart and the third was performed 2
months after the second one. The amount of energy used was 1W
for 0.2 seconds, delivering a total of 230 to 550 spots (50–100 mm
spot size) with the laser treatments. IOP was monitored using a
tonometer (Tono-Pen; Mentor, Norwell, MA). Figure 1 illustrates
the progression of IOP in the 12 rats with monocular laser
treatments measured from the operated and unoperated eyes. In
this model, retinal ganglion cell (RGC) loss was previously
demonstrated to be roughly 33% after 3 weeks of elevated IOP.
Anterograde tracing of retinal projections, CTb
immunocytochemistry
Injection of Cholera toxin fluorochrome conjugates for
qualitative study. Rats with monocular laser surgery (n=4 of
the 12 rats described in laser treatment) were anesthetized with a
mixture of ketamine (50 mg/kg) and xylazine (25 mg/kg). Eyes
were additionally anesthetized locally using topical application of
oxybuprocaı ¨ne chlorhydrate. Two rats received a 0.5 mg
intraocular injection (6 ml) of Cholera toxin subunit b (CTb)
Alexa Fluor 594 conjugate (red fluorescence, #C-22842,
Molecular Probes, CA) in the operated right eye and a 0.5 mg
intraocular injection (6 ml) of CTb Alexa Fluor 488 conjugate
(green fluorescence, #C-22841, Molecular Probes, CA) in the
unoperated (control) left eye. The 2 other rats received the same
two intraocular injections of CTb fluorochromes but with the
reverse Alexa Fluor 488 conjugate in the operated right eye and
Alexa Fluor 594 conjugate in the control left eye.
Injection of Cholera toxin for quantitative analysis. Rats
with monocular laser surgery (right eye, n=8 of the 12 rats
described in laser treatment) and controls with no laser surgery
(n=8) were anesthetized with a mixture of ketamine (50 mg/kg)
and xylazine (25 mg/kg). Eyes were additionally anesthetized
locally using topical application of oxybuprocaı ¨ne chlorhydrate.
Rats with monocular induced glaucoma received a 0.5 mg
injection (6 ml) of CTb (#130A, List Biological Laboratories Inc)
in the operated eye. Control rats with no laser surgery received the
same injection in their right eye.
Treatment of Brain Sections and CTb
Immunocytochemistry. For both the CTb fluorescence and
diaminobenzidine (DAB) studies, 48 hr after the injection, all
animals were deeply anesthetized with a lethal intraperitoneal
injection of sodium pentobarbital (150 mg/kg) and perfused
intracardially with warm (37uC) heparinized saline followed by
Figure 1. Levels of intraocular pressure (IOP) of rats following treatment with Argon laser photocoagulation. IOP in the operated eyes
are compared with that in the unoperated eyes from the same individuals (n=12). Arrows represent the times of the three laser surgeries. The serial
sequence of laser treatments assures a long-term chronic elevation of IOP.
doi:10.1371/journal.pone.0003931.g001
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post-fixed overnight in a mixture containing the same fixative with
30% sucrose for cryoprotection at 4uC. Serial coronal sections
were made at 50 mm on a freezing microtome and all brain
sections were collected. Sections from the animals injected with the
CTb anterograde tracer coupled to a fluorochrome were directly
mounted on slides, dehydrated and coverslipped.
All sections from all animals injected with CTb were processed
at the same time to obtain identical levels of tissue staining for data
analysis. Endogenous peroxidase was first suppressed using a
solution of 50% ethanol in saline with 0.03% H2O2. Free-floating
sections were rinsed briefly in PBS (0.01 M, pH 7.2) containing
0.3% Triton and blocked with 1% bovine serum albumin. Sections
were incubated in the anti-CTb primary antibody (dilution
1:3,000) for 3 days at 4uC. Immunoreactivity was visualized using
a Vectastain ABC Elite kit (PK-6100, Vector Laboratories,
Burlingame, CA), followed by incubation in 0.2% 3,39- DAB
with 0.5% ammonium nickel sulfate and 0.003% H2O2 in Tris
buffer (0.05 M, pH 7.6). Sections were then mounted on slides,
dehydrated and coverslipped.
Quantification of retinal projections
Retinal projections to the brain were quantified on sections
processed for DAB immunocytochemistry, based on a published
methodology [34] that has been applied in several previous studies
of brain organization [35–37]. Briefly, quantitative levels of the
optically dense DAB immunolabel product were measured using
computer-assisted image analysis (Biocom, Les Ulis, France).
Optical density of label was measured bilaterally in each structure
from digitized images. Quantification of label is determined from
the total integral optical density of labeling. Integral density takes
into account both the surface area and pixels density. The integral
optical density was obtained by first subtracting the background
density value. Optical density was measured from all the sections
of each structure that receives RGC fiber projections except for
the superior colliculus (1 of 2 sections).
Analysis of Retinal Opsins
At the end of the behavioral study the two retinas were pooled
from each of the animals (n=5 binocular induced glaucoma rats
and n=5 control rats, age 14–16 months). Retinas were collected
from the animals between ZT8-ZT9, after the animals had been
re-entrained to a 100 lux LD cycle. Total RNA was extracted
using GenEluteTM Mammalian Total RNA Miniprep Kit (Sigma)
according to the manufacturer’s instructions and subsequently
subjected to DNase digestion. Total RNAs was reverse transcribed
using random primers and MMLV Reverse Transcriptase
(Invitrogen). Real-time PCR was then performed on a Light-
Cycler
TM system (Roche Diagnostics) using the light Cycler-DNA
Master SYBR Green I mix. The efficiency and the specificity of
the amplification were controlled by generating standard curves
and carrying out melting curves and agarose gels of the amplicons
respectively. Relative transcript levels of each gene were calculated
using the second derivative maximum values from the linear
regression of cycle number versus log concentration of the
amplified gene. Amplification of the non cyclic control gene
36B4 was used for normalization. Each reaction was performed in
duplicate. Primer sequences were the following:
SW opsin forward 59 -GTACCACATTGCTCCCGTCT-39
SW opsin reverse 59 -AGACCTGCTACAGAGCCCAA-39
MWopsinforward59,-GCCTTATGGCCTGAAGACATC-39
MW opsin reverse 59-CTGTTGCTTTGCCACTGCTC-39
Rhodopsin forward 59-GCAGTGTTCATGTGGGATTG-39
Rhodopsin reverse 59-CTGCCTTCTGAGTGGTAGCC-39
Melanopsin forward 59-ATCTGGTGATCACACGTCCA-39
Melanopsin reverse 59-TAGTCCCAGGAGCAGGATGT-39
Thy1 forward 59-CAGGACGGAGCTATTGGCACCAT-39
Thy1 reverse 59-ACGGCAGTCCAGTCGAAGGTTCT-39
PACAP forward 59-ACAGCGTCTCCTGTTCACCT-39
PACAP reverse 59-CCTGTCGGCTGGGTAGTAAA-39
36B4 forward 59-GCTCCAAGCAGATGCAGCAG-39
36B4 reverse 59-CAGCTGGCACCTTATTGGCC -39.
Entrainment of circadian locomotor activity rhythms
For monitoring locomotor activity, rats operated bilaterally to
induce experimental glaucoma were used. A total of 10 rats (n=5
with binocular raised IOP, n=5 controls) were housed individ-
ually in cages equipped with passive infrared motion captors
placed over the cages and a computerized data acquisition system
(CAMS, Circadian Activity Monitoring System, INSERM,
France). Rats were initially maintained for 26 days under a
12:12 LD cycle with broad-band white light (100 lux). Animals
subsequently underwent a 6 hr phase delay of the LD cycle,
associated with successive decreases of light intensity (from 100 to
10 lux and subsequently from 10 to 1 lux).
Activity records were analyzed with the Clocklab software
package (Actimetrics, Evanston, IL). The time of locomotor
activity onsets was determined using the Clocklab onset fit
algorithm. Animals were considered to be entrained when the fit
of the least squares regression line of the activity onsets was stable
in relation to lights-off for at least 7 days of in LD. The phase
angle, defined as the time difference between the onset of the
activity rhythm and time of lights-off was determined for each
animal (see [38]).
Statistical Analysis
Data were analyzed using the SigmaStat software (Systat
Software Inc., Point Richmond, CA). The Shapiro-Wilk W test
was used to test for normality. For comparisons between two
groups, parametric t-test was used when data were normally
distributed and non-parametric Mann-Whitney test when nor-
mality was not achieved. Data is expressed as mean6S.E.M.
Results
Consequences of chronic elevated IOP on retinal
projections
All operated eyes of animals treated with laser surgery displayed
a consistent chronic increase in IOP (Fig 1). To assess the
consequences of chronic hypertension on injury to RGC axonal
projections to the brain, intraocular injection of two different
fluorescent anterograde tracers were made in the same individual:
a green fluorescent tracer in the laser-operated glaucomatous eye
and a red fluorescent tracer in the opposite intact eye. Using this
coupled, double fluorescence technique, the patterns of retinal
projections from the normal and glaucomatous eye can be
examined on the same brain section by simply changing the
fluorescence excitation filters. Comparison of the retinal fiber
innervations (Fig. 2) shows a marked reduction in the density and
topographical coverage of the retinal fibers emanating from the
glaucomatous eye to all structures examined (SCN, dLGN, SC; see
below for IGL ventral lateral geniculate nucleus: vLGN,
pretectum: PRT). The loss of retinal innervation from the
Glaucoma and Circadian System
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retinal fibers are present. The dLGN is also affected, with an
absence of label in the ventrolateral portion of the contralateral
nucleus and a noticeable reduction of the ipsilateral component of
the projection. The SC shows a complete loss of fibers in the
lateral region. This lateral part of the SC and the ventrolateral part
of the dLGN correspond to the temporal and dorsal parts of the
visual field [39–40]. Although there was variability between
individuals in the topographical pattern and degree of reduction of
RGC fiber innervation, all 4 cases examined demonstrated a
uniform decrease in innervation of the SCN coupled with a patchy
distribution or empty regions in the dLGN and SC.
Quantification of retinal projections to visual and non-
visual structures
While the double fluorescent tracing method allows a direct
qualitative assessment of the topographical distributions of RGC
fibers from glaucomatous and control eyes, the use of different
fluorescent filters precludes a precise quantitative comparison. For
this reason we used optical density analysis of digitalized images
from brain sections that were processed for DAB immunocyto-
chemistry [34,36]. All control rats (8/8) showed dense retinal
projections to the all target structures (Fig. 3A). Retinal projections
were predominantly contralateral for structures such as the dLGN
(94.360.9%), the vLGN (89.161.7%), the PRT (92.861.2%) and
the SC (99.860.1%). In the SCN and intergeniculate leaflet (IGL)
projections were more bilaterally balanced with respectively
65.161.6% and 67.462.8% of the retinal fibers on the
contralateral side. In the SCN, the density of the projection was
greater ventro-laterally. For the dLGN, vLGN, IGL and PRT,
retinal projections on the contralateral side are relatively
homogeneous and occupy virtually the entire extent of each
nucleus. Ipsilaterally retinal axons in these structures are sparse
and typically distributed in patches, for example in the
dorsomedial dLGN and the rostral SC.
Chronically elevated IOP alters these topographical distribu-
tions and causes a reduction of the RGC projections in brain
structures, but these features vary depending on the individual
case. Some laser operated animals showed a uniform reduction of
retinal projections in all structures, although the fiber distribution
appeared almost normal within the nuclei (Fig. 3B). Other animals
displayed a patchy reduction of the density of retinal projections in
specific sub-regions of the different brain structures (Fig 3C). In
this case, the pattern of the projections onto the contralateral SC
suggested that the retinal quadrants most affected were located
ventral and lateral to the optic disc. Finally, other individuals with
laser-induced glaucoma had severe reductions of retinal projec-
tions to all structures, although some sparse patches were observed
in the contralateral SC (Fig. 3D). Based on the fiber pattern
distribution in the contralateral SC, two of these rats conserved
sparse projections from the dorso-temporal region of the retina
and the other rat from dispersed retinal regions.
The quantitative analysis of the mean densities of retinal
projections to different brain structures for operated and control
groups and the relative percent reduction (compared to the
average values for the controls) are illustrated in Figure 4A–B.
Two operated animals omitted from the analysis due to an
unacceptable number of missing sections showed qualitative
Figure 2. Retinal ganglion cell projections to the ipsilateral and contralateral suprachiasmatic nucleus (SCN), dorsal lateral
geniculate nucleus (dLGN) and superior colliculus (SC) from a control and glaucomatous eye. The unoperated control eye was injected
with a red fluorescent CTb anterograde tracer (A) and the operated glaucomatous eye with a green fluorescent CTb tracer (B). The images in A and B
are taken from the same sections but using different excitation filters. For each of the structures illustrated, the brain hemisphere ipsilateral to the
injected eye is to the left and contralateral to the injection is to the right. Thus, the ipsilateral dLGN and SC (red: control) correspond to the same
hemisphere as the contralateral dLGN and SC (green: operated). Note that projections to the SCN and SC (montage of 3 photomicrographs) are
markedly reduced and that the topographical distribution of the projection in the dLGN is also considerably altered. Part of the material shown is
modified from a previous review [69].
doi:10.1371/journal.pone.0003931.g002
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of variability in the glaucomatous rats, the reduction in retinal
fiber density in different structures ranged from 49.7612.6 %
(vLGN) to 71.769.4% (SCN) and was significant for each
structure (Mann Whitney; p,0.05) and for the total density
summed for all the structures (60.166.9%, Mann-Whitney,
p,0.05; Fig 4B).
Light entrainment of locomotor activity is altered in
glaucoma
We then assayed the ability of rats with binocular induced
glaucoma to entrain their daily locomotor activity to successive
6 hr delays of LD cycles each coupled with 1 log unit decreases in
light levels (100, 10 and 1 lux). Measures of IOP in both
glaucomatous eyes showed increases comparable to those recorded
for the monocularly operated animals, ranging from
16.161.14 mm Hg before surgery to 31.061.90 mm Hg follow-
ing the surgical procedures. Locomotor activity rhythms (double
plotted actograms) are shown for a control and operated rat with
binocular experimental glaucoma (Fig. 5A). Both control and
operated rats were capable of entrainment to the LD cycles at all
light levels. However, the animals with binocularly induced
experimental glaucoma displayed a behavioral pattern that was
characterized by a delay to entrain to the new LD cycle and a high
degree of variability for activity onsets in relation to the beginning
of the dark phase.
This is illustrated more clearly in the group analysis in Figure 5B
where the phase angles of individual activity onsets are shown.
The results indicate that the glaucomatous rats require on the
average more time to entrain to the new LD cycle but this was
only significant when the light level was lowered to 1 lux
(control=5.860.86 days, operated=9.861.50 days, t-test,
p,0.05; Fig. 5C). The histograms in Figure 5C also show that
in comparison to controls, rats with binocular elevated IOP are
unable to precisely synchronize their activity to the LD cycle at all
light levels, expressed as a significantly greater variability in
activity onsets with respect to the beginning of the dark phase (100
lux: control=0.1760.02 hrs; operated=0.3660.08 hrs, t-test,
p,0.05; 10 lux: control=0.2360.03 hrs; operated=0.466
0.10 hrs, t-test, p,0.05; 1 lux: control 0.3560.02 hrs; operated
=0.6460.06 hrs t-test, p,0.005).
At the end of the experiment, rats were released in constant
darkness to assess whether the animals were entrained to the
previous LD cycle at 1 lux light level or if there was a masking
component (Fig. 5A–B). Both the control and operated rats were
entrained prior to release in constant darkness since the onset of
free-running activity extrapolated back to the first day in darkness
started to derive from the previous onset point. There was no
difference between the two groups in their endogenous free-running
periods (control 24.0960.09 hrs; operated=24.1760.71 hrs;
Mann-Whitney, p=0.421) or in the variability of activity onsets
(t-test: p=0.533). This suggests that the onset variability of operated
Figure 3. RGC axonal projections to the brain from the eye of a control animal (A) and from the operated eye of animals with
monocular induced glaucoma (B–D) following injection with anterograde tracer (CTb). (A) Retinal projections to the brain from a control
eye illustrating the normal pattern of dense fiber innervation in the different visual structures. Several cases of experimental glaucoma are illustrated
to show the variation of RGC fiber loss in the brain that are (B) reduced but conserve an even distribution of retinal fibers in each visual structure, (C)
reduced and show an irregular patchy distribution or (D) are almost completely abolished except for a few small pathes of label. Only contralateral
sides of the dLGN and SC are shown. SCN, suprachiasmatic nucleus; dLGN, dorsal lateral geniculate nucleus; vLGN) ventral lateral geniculate nucleus;
IGL, intergeniculate leaflet; SC, superior colliculus.
doi:10.1371/journal.pone.0003931.g003
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glaucomatous rats rather than of circadian clock function itself.
Alteration of retinal opsin mRNAs and ganglion cell
markers in glaucoma
Finally, real time quantitative PCR was used to evaluate the
expression of different retinal opsins as well as the expression of a
specific ganglion cell marker (Thy1) and pituitary adenylate
cyclase peptide (PACAP) a neurotransmitter co-expressed in
melanopsin RGCs (Fig. 6). As expected, mRNA of melanopsin
and Thy1 are significantly decreased in eyes with raised IOP (t-
test, p,0.01). In contrast, PACAP mRNA expression remains
unchanged (t-test, p=0.831). However, an unexpected finding was
that all opsin mRNAs from the outer retina (SW, MW opsins and
Figure 4. Quantification of the RGC axon terminal projections to all visual structures in control and glaucomatous animals.
Structures analyzed in control animals (n=8, black) and operated animals (n=6, white) include the suprachiasmatic nucleus (SCN), dorsal lateral
geniculate nucleus (dLGN), ventral lateral geniculate nucleus (vLGN), intergeniculate leaflet (IGL), pretectum (PRT) and superior colliculus (SC). For
each structure, the ipsi and contralateral densities are summed and represent the integral optical density (IOD) for all the sections obtained from the
entire structure. The scale on the right corresponds to values for the total summed density of RGC projections for all structures). The difference in IOD
was significant for all structures and for the total amount of projections. (Mann Whitney; * p,0.05). B shows the percent reduction of the IOD value of
retinal fiber projections in visual structures of laser-operated eyes compared to the mean IOD value of the projections from unoperated control eyes.
Percent reductions range from ,50–70% depending on the structure. Errors bars in A and B are S.E.M.
doi:10.1371/journal.pone.0003931.g004
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mental glaucoma (t-test, p,0.001).
Discussion
Previous studies of animal models of experimental glaucoma
secondary to chronically elevated IOP have demonstrated
significant RGC loss ranging from 30% to 90% depending on
the method employed, time course and experimental model
[14,33,41–43]. The assay of RGC degeneration in the retina is a
gold standard for assessing the consequences of experimental
glaucoma, but in the present study we focused on the loss of
central RGC fiber projections in order to gain a comprehensive
view of the quantitative and qualitative alterations in the target
structures that process visual and non-visual information in the
brain. To our knowledge, only two (contradictory) studies have
examined the consequences of ocular hypertension on the
alteration of RGC fiber projections. One HRP-tracing study in
the rat SC [44] claimed a complete lack of anterograde transport,
while the second study found 20–90% losses of retinal projections
in the magno- and parvocellular layers of the monkey dLGN
(silver grain counts; [45]).
Anterograde tracing in the hypertensive rat model indicates that
experimental glaucoma induces an overall reduction of the retinal
projections to the brain (,60%) while the same analysis following
severe degeneration of outer retinal photoreceptors reveals no
effects [37]. The reduction is particularly significant for the SCN,
the main target of an almost exclusive innervation from
melanopsin RGCs [26] that shows a mean reduction of ,71%.
The dLGN; IGL and PRT show mean reductions ranging from
,60–65% while the vLGN and SC show a reduction of roughly
50%. This suggests that melanopsin RGCs are equally susceptible
to degeneration as other RGCs in raised IOP, consistent with the
65–80% reduction of melanopsin RGCs in the study by Jakobs et
al. [14]. These two results contrast with a third report describing a
resistance of the melanopsin cell population to IOP induced injury
[32]. This discrepancy may arise from the fact that the latter study
used a small sample size, short survival periods (,14 days) and
different methods to quantify the reduction in melanopsin RGCs
and in the total RGC population.
A consistent feature of the reduction of RGC projections, despite
the reliable increase of IOP induced by the laser surgery, was the
variability observed between individual animals in both the extent
and the topographical pattern of loss of RGC fibers. The variation
of RGC, optic nerve fiber and visual field loss following increased
IOP is a characteristic feature in both experimental and human
glaucoma [4]. For example, in mouse models of hereditary
increased IOP, 28% of the mice show little or no indication of
Figure 6. Quantification of mRNA expression of retinal opsins, Thy1 and PACAP. Short wavelength cone (SW), mid-wavelength cone (MW)
opsins, rhodopsin and melanopsin mRNA expression are all significantly reduced in experimental glaucoma. The specific RGC marker Thy1 was also
significantly reduced whereas PACAP expression is unchanged (t-test, * p,0.05; ** p,0.005.) Both of the retinas from each of the binocularly
operated (n=5) and control rats (n=5) were used.
doi:10.1371/journal.pone.0003931.g006
Figure 5. Representative double plot actograms and phase angle plots for a control rat and a rat with experimentally induced
binocular glaucoma. Animals are first entrained under a 12:12 light:dark (LD) cycle at 100 lux light (actograms shown in A). After 26 days, the LD
cycle was shifted 6 hrs (delay) and the light level was decreased to 10 lux. After 35 days, the light LD cycle was again shifted by 6 hrs and the light
level decreased to 1 lux (45 days). Animals were then released into constant darkness to assess whether the animals were entrained to the previous
LD cycle. The three successive 12L:12D light cycles (from 100-10-1 lux) are shown above the actograms and the days corresponding to the lux levels
of the light phase are indicated on the right. The black bars indicate constant darkness. Although both groups of animals entrained to each of the
shifted LD cycles, glaucomatous rats show a greater variability in locomotor activity onsets with respect to the beginning of the dark phase. Some
glaucomatous rats also show variability in activity offsets at lights on and components of activity drift during the dark phase. This is illustrated in B for
the phase angle plots of the activity onsets of individual control rats (n=5, left) and rats with binocular glaucoma (n=5, right). (C) Quantification of
the number of days necessary to entrain to a new light-dark cycle (left) and quantification of the activity onset variability with respect to the
beginning of the dark phase (right) for both groups. Onset variability was calculated from the last 15 days of each LD cycle, when all animals
displayed stable entrainment. (t-test, * p,0.05; ** p,=0.005).
doi:10.1371/journal.pone.0003931.g005
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differencesbetween the left and righteyesina singleindividual [14].
Furthermore, the topographical pattern of degeneration across the
retinal surface can show considerable variation [14,46]. The nature
of the mechanistic link between high intraocular pressure and loss of
retinal ganglion cells is still not fully understood and although raised
IOP is clearly an important risk factor, patients with ocular
hypertension do not invariably progress to clinical glaucoma and
RGC degeneration, even over long-term periods [2,4,47–49].
The reduction in mRNA of melanopsin and of the ganglion cell
marker Thy1 also confirms the overall decreases of the RGC
population and of melanopsin RGCs. In contrast, PACAP, which
is co-expressed in melanopsin RGCs [50] remains unchanged.
However, it is unclear whether PACAP is also expressed in other
retinal neurons and a decrease in melanopsin mRNA without a
concomitant decrease in PACAP is observed in rats treated with
N-methyl-N-nitrosourea (MNU), a pharmacological agent causing
photoreceptor apoptosis [51].
An unexpected but significant finding is that mRNA opsin
expression from outer retinal photoreceptors (MW cones, SW
cones, rods) were all found to be under expressed. Although the
question of whether other retinal cell types are altered in glaucoma
is still a matter of debate, Jakobs et al. [14] using well-characterized
cell markers for specific amacrine and bipolar cells coupled with
morphological analysis of soma and dendritic architecture argue
that glaucoma affects exclusively the RGCs. Most early histopath-
ological studies reported no photoreceptor loss in human eyes with
primary open angle glaucoma [52] or in a monkey model of
glaucoma [53]. More recent data describes minor abnormalities
without cell loss in the outer retina, including swollen photorecep-
tors in both the human disease and in the monkey [54].
Furthermore, multifocal ERG studies have shown that the outer
retina is functionally affected in experimental glaucoma [55–56].
Finally, a recent investigation [57]using in situ hybridization showed
a reduction in the expression of MW/LW and SW cone opsin
mRNAs in monkeys with chronic ocular hypertension, consistent
with our results. In contrast no changes in the rod opsin mRNA
level were observed. Taken together, these data suggest that
althoughtheouterretinaisnotanatomicallyalteredinexperimental
or human glaucoma, cone and rod opsin mRNAs are under
expressed and may be functionally impaired. The reduced level of
mRNA opsins may result directly from the chronic increase in IOP
or, alternatively, may be an indirect effect related to the partial loss
of melanopsin RGCs and a subsequent disruption of the circadian
regulation of retinal physiology and outer retinal photoreceptor
processes [58]. If the retinal clock is deregulated, this may have
potentially important consequences on gene cycling, photopigment
regeneration and retinal function [59] in severe glaucomas.
The reduction of melanopsin RGCs and their innervation of the
SCN impacts on the ability of glaucomatous rats to entrain to
light. We used an entrainment paradigm since this assay is
reported to be more sensitive for detecting entrainment deficits
compared to single light-pulse phase shifts in both animals [60]
and humans [61] and is more relevant to real-life conditions that
human patients are exposed to. Rats with binocular hypertension
require more time to re-entrain to a shifted LD cycle at low light
levels compared to control rats and display greater variability in
the activity onsets. Mice invalidated for melanopsin show a deficit
in their ability to entrain at low light levels, to phase shift to light
[20,21,26,38], have impaired masking responses to light [22] and
show severely reduced photic responsiveness in the SCN [28].
However, the total loss of melanopsin photopigment in Opn4
2/2
mice is not equivalent to the situation in glaucomatous rats (or
human glaucoma), where a variable proportion of melanopsin
RGCs (and their rod/cone inputs) are absent. Our results are
similar to the anatomical and behavioral alterations recently
reported using a targeted saporin-based immunotoxic technique
that results in a partial ablation of melanopsin RGCs [62].
In humans, it has been reported that patients with different
degrees of blindness resulting from various ocular pathologies
show sleep disturbances and abnormal circadian rhythms [29–31].
These disturbances were attributed to a lack of light input to the
circadian clock and are correlated with the degree of loss of light
perception. Patients with the lowest level of conscious light
perception show the greatest degree of sleep impairments. In the
study by Tabandeh et al. [31] the patient group with optic nerve
disease/glaucoma showed a higher likelihood of sleep disorders,
although this group contained individuals with light perception
and others with no light perception. Glaucoma patients have been
shown to exhibit relative afferent pupillary defects in early stages
[63–65] and a prevalence of sleep disorders in later stages [66–67].
In our laboratory, preliminary studies of patients with severe open
angle bilateral glaucoma show a high variability in both the
normal time to bed and in the dim-light melatonin onset [68]
which we speculate represent the main manifestations of circadian
disorders in this group.
Here, we provide evidence that chronic increase IOP in a
rodent model of glaucoma leads to a decrease in the melanopsin
RGC axonal innervation of the SCN and an alteration in the
photic response to light. The alteration of entrainment of
locomotor activity in this model suggests that patients with severe
bilateral glaucoma may show an increased propensity for
chronobiological disturbances. Our data and that of previous
studies support the idea that RGC loss due to glaucoma affects
both visual and non-visual functions. Concerns for health and
quality of life for patients with glaucoma should thus not be limited
to the detection and prevention of visual impairments but should
also consider the potential impacts on altered circadian entrain-
ment and sleep disturbances.
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